FDA Investigator Jennifer L Johnson
Jennifer L Johnson has conducted inspections on 85 sites in 2 countries as of 22 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
85
Last Inspection Date:
22 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Jennifer L Johnson:
Adam S Freeman,
Alex G Kalugin,
Alla Dubrovsky,
Amanda N Schaupp,
Andrew B Slarve,
Andrew E Kay,
Andrew K Haack, PhD,
Andrew T Todd,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anna L Viveros Hernandez,
Annie H Lam,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Beverley A Phillips,
Breena L D'ambrogi,
Brian R Henderson,
Brian R Yaun,
Bruce D Broidy,
Bryan S Roddy,
Capri R Woolridge,
Carl Lee,
Catherine D Djordjevic,
CDR Rochelle B Young, RPh, MSA,
Celeste K Wong,
Charles E Frelix,
Charles M Spyr,
Christine M Parmentier,
Christopher Do,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Cynthia J Tsui,
Cynthia L Ford,
Damon A Growl,
Dana A Razzano,
Daniel J Gorski,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David A Laplante,
David A Lum,
David A Paterson,
David G Eng,
David J Leray,
Deborah K Richardson,
Dena L Jacobs,
Dennis R Downer,
Diane Cvan Leeuwen,
Diyo R Rai,
Dustin P Tran,
Dustin R Abaonza,
Edna J Hidalgo,
Edwardstine J Reese,
Elaine S Chow,
Elisabeth A Drevet,
Elodie X Tong Lin,
Emal Wahab,
Emmanuel O Kerry,
Eric W Anderson,
Erica R Pomeroy,
Estefania Fernandez,
Frank P Bianco,
Gina M Hall,
Hans T Meyers,
Helen J Hamaoka,
Henry K Lau,
Huy T Pham,
Ifueko Osemwota,
Ingrid A Zambrana,
Ismael Garibay,
James C Lee, PharmD,
James C Yee,
James S Cartwright,
Jane G Choi,
Janice Wai,
Jannifer L Degroot,
Jazmine M Welcher,
Jeanne A Young,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer R Johnson,
Jennifer S King,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Gonzalez,
John A Liu,
John N Woodall,
John R Myung,
Jorge L Bertran,
Joseph A Seitz, III,
Joseph Tibay,
Joshua M Adams,
Juan A Morales,
Jude C Dikes,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen L Robles,
Karla J Gibler,
Kawshalya Pathiraja,
Kenneth O Gee, PhD,
Keren Arkin,
Kevin P Foley,
Kim Lthomas Cruse,
Kimiko G Casuga,
Kristin M Abaonza,
Lance Mde Souza, MBA,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
Lea Lakes,
Ligia M Cline,
Lija V Fellows,
Lilly O Barton,
Linda Linh N Adams,
Linda S Shook,
Lisa H Nakagawa,
Lorraine N Williams,
Lourdes Andujar,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Luis A Solorzano,
Lydia S Chan,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Mancia R Walker,
Maridali Deleon Torres,
Marie K Kinkade,
Marissa J Chan,
Mark I Nakano,
Marshalette O Edwards,
Martin R Vowell,
Mary C Acton,
Mary C Wall,
Mary R Hole,
Matthew K Wong,
Mcgrewp,
Melody M Ragasa Leong,
Michele R Douglas,
Michelle L Tripp,
Monique C Lo,
Ngoc B Kelsch,
Nicholas L Hunt,
Nicole Yuen,
Nina D Patel,
Nympha V Florendo,
Pablo Alcantara,
Patrick B Cummings,
Paula P Demichael,
Peter E Baker,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Rafeeq A Habeeb,
Randall J Plunkett,
Randall P Zielinski,
Raymond T Oji,
Rebecca E Sulpacio,
Roberta K Smith,
Robles,
Roger D Gawne,
Ronald P Boyce,
Roy C Stephens,
Rumany C Penn, PharmD,
Sabino S Camacho,
Sandra S Saniga,
Scott N Lim,
Scott W Fox,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Sharon K Thoma, PharmD,
Sharon L Shane,
Siobhan A Gallagher,
Sparky L Bartee,
Stephanie A Slater, MS,
Steven C Himebaugh,
Steven M Galvez,
Stuart W Russell,
Tamayo C Barnes,
Terrence Gee,
Thea C Grome,
Thomas N Adjabeng,
Thomas W Gordon,
Tiffany Chao,
Timothy C Grome,
Tressa T Lewis,
Uduak M Inokon,
Vi T Au,
Victoria L Morgan,
Walden H Lee,
Wen Jun Peng,
Willemsj,
William J Foust,
William J Weis,
William V Millar,
Yen Tso Kuo
Jennifer L Johnson's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more